Tomomi Suzuki, MD, PhD

Video

Endothelialization of Amplatzer PFO Occluder Device 12 Months Post Implantation

01/31/2022

Yasuhiro Tanabe , MD, PhD;

Yoshihiro J. Akashi , MD, PhD;

Tomomi Suzuki , MD, PhD;

Shingo Kuwata , MD, PhD;

The current guidelines recommend at least 6-month antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.” This is the first evaluation of PFO occluder device...

The current guidelines recommend at least 6-month antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.” This is the first evaluation of PFO occluder device...

The current guidelines recommend...

01/31/2022

Journal of Invasive Cardiology

Tanabe PFO Occluder TN

Clinical Images

Endothelialization of Amplatzer PFO Occluder Device 12 Months After Implantation: First-in-Human Angioscopic Assessment

01/28/2022

Yasuhiro Tanabe , MD, PhD;

Yoshihiro J. Akashi , MD, PhD;

Tomomi Suzuki , MD, PhD;

Shingo Kuwata , MD, PhD;

The current guidelines recommend at least 6 months of antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.”

The current guidelines recommend at least 6 months of antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.”

The current guidelines recommend...

01/28/2022

Journal of Invasive Cardiology

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar